Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2016 - 2025)
Phibro Animal Health has reported Depreciation & Amortization (CF) over the past 13 years, most recently at $12.9 million for Q4 2025.
- Quarterly results put Depreciation & Amortization (CF) at $12.9 million for Q4 2025, up 11.38% from a year ago — trailing twelve months through Dec 2025 was $50.7 million (up 30.21% YoY), and the annual figure for FY2025 was $45.6 million, up 26.06%.
- Depreciation & Amortization (CF) for Q4 2025 was $12.9 million at Phibro Animal Health, roughly flat from $12.8 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for PAHC hit a ceiling of $12.9 million in Q4 2025 and a floor of -$24.0 million in Q2 2021.
- Median Depreciation & Amortization (CF) over the past 5 years was $8.7 million (2023), compared with a mean of $7.5 million.
- Biggest five-year swings in Depreciation & Amortization (CF): plummeted 99.94% in 2021 and later soared 168900.0% in 2022.
- Phibro Animal Health's Depreciation & Amortization (CF) stood at $8.0 million in 2021, then increased by 6.22% to $8.5 million in 2022, then increased by 4.84% to $8.9 million in 2023, then grew by 29.9% to $11.6 million in 2024, then rose by 11.38% to $12.9 million in 2025.
- The last three reported values for Depreciation & Amortization (CF) were $12.9 million (Q4 2025), $12.8 million (Q3 2025), and $12.4 million (Q2 2025) per Business Quant data.